Health Nov 30 FDA panel review final hurdle for Merck’s COVID-19 pill By Matthew Perrone, Associated Press
Health Jun 01 Scientists hope they’re closing in on a cure for COVID-19 Doctors have some medications they can use to treat the effects of COVID-19, but scientists are searching for effective drugs that target the virus itself. Two promising drugs in the pipeline offer hope for a cure. By Corey Meador
Politics Aug 14 Merck CEO steps down from presidential council after Charlottesville The CEO of the nation's third largest pharmaceutical company is resigning from the President's American Manufacturing Council citing "a responsibility to take a stand against intolerance and extremism."… By Associated Press
Science Jun 10 How close is the Ebola vaccine? Is the world prepared to fight the next Ebola outbreak? NewsHour provides an update on Ebola vaccine testing in West Africa. By Caleb Hellerman, Global Health Reporting Center
Science Sep 24 Trial Shows First HIV Protection from Vaccines Promising results released Thursday from an HIV vaccine trial in Thailand show for the first time that a vaccine may prevent HIV infection.
Mar 09 Merck/Schering-Plough Merger Would Create Second-Largest Drug Company By PBS NewsHour Two major pharmaceutical companies announced plans to merge Monday in a $41.1 billion cash-and-stock deal to form the world's second-largest prescription drug maker. Continue reading
Oct 23 Greenspan Calls Financial Crisis a ‘Credit Tsunami’ By PBS NewsHour In testimony before Congress Thursday, former Federal Reserve Chair Alan Greenspan said that the current financial crisis is a "once in a century credit tsunami" that will continue to impact the U.S. economy, spurring more job losses to come. Continue reading
Oct 22 Weak Earnings Reports Trigger Market Losses By Admin, PBS NewsHour A number of poor earnings reports from major corporations, including Wachovia Corp. and Merck & Co., caused U.S. stocks to drop more than 500 points Wednesday. Continue reading
Apr 15 Watch Merck Faces New Questions Over Vioxx Risks, Research Pharmaceutical company Merck knew in 2001 that its arthritis drug Vioxx could harm patients and used staffers to "ghostwrite" favorable research on the drug, articles in the Journal of the American Medical Association report. Susan Dentzer examines the charges. Continue watching
Jan 23 Watch Study Poses New Questions About Cholesterol Drugs The makers of the cholesterol drug Vytorin pulled its telelvision ads off the air on Tuesday, after a study found the drug was no more effective at reducing the risk of heart attack than one of its generic counterparts. Two… Continue watching